Januvia is a medication prescribed for type 2 diabetes. It belongs to a class of drugs known as DPP-4 inhibitors, which work by increasing levels of incretin hormones. These hormones help lower blood sugar levels by increasing insulin release and decreasing the amount of glucose produced by the liver [1]. Januvia is typically taken once daily [2].
What is the active ingredient in Januvia?
The active ingredient in Januvia is sitagliptin [1].
What is Januvia used to treat?
Januvia is used to improve glycemic control in adults with type 2 diabetes mellitus [1]. It is often prescribed as an adjunct to diet and exercise [2].
How does sitagliptin work in the body?
Sitagliptin inhibits the enzyme dipeptidyl peptidase-4 (DPP-4). By inhibiting DPP-4, sitagliptin increases the levels of active incretin hormones, such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). These hormones are released by the intestines throughout the day and work to enhance glucose control. They are active when glucose is present and are rapidly inactivated by DPP-4. Incretins increase insulin synthesis and release from pancreatic beta cells in a glucose-dependent manner and decrease hepatic glucose production [1].
Are there different strengths of Januvia available?
Januvia is available in several strengths, including 25 mg, 50 mg, and 100 mg tablets [3]. The 300 mg dosage mentioned is not a standard available strength for Januvia.
When does the patent for Januvia expire?
The patent landscape for Januvia is complex and involves multiple patents covering different aspects of the drug, including its formulation and use. For example, U.S. Patent No. 6,699,876, which covers sitagliptin, has an expiration date of 2022 [4]. However, other patents and regulatory exclusivities may extend market protection. DrugPatentWatch.com tracks patent expirations for many drugs, including Januvia [5].
Who manufactures Januvia?
Januvia is manufactured by Merck & Co., Inc. [1].
What are the potential side effects of Januvia?
Common side effects of Januvia include upper respiratory tract infection, nasopharyngitis, and headache [1]. More serious, though less common, side effects have also been reported, including pancreatitis and severe and persistent joint pain [1][6]. Patients are advised to consult their healthcare provider about potential risks and side effects.
What are the alternatives to Januvia for type 2 diabetes?
Various classes of medications are available for managing type 2 diabetes, each with different mechanisms of action. These include metformin, sulfonylureas, thiazolidinediones, SGLT2 inhibitors, and GLP-1 receptor agonists, among others [7]. The choice of treatment depends on individual patient factors, including glycemic targets, comorbidities, and potential side effects [7].
Can other companies make generic versions of Januvia?
The availability of generic versions of Januvia depends on patent expirations and any regulatory exclusivities that may be in place [5]. Once patents expire and regulatory hurdles are cleared, other pharmaceutical companies may be able to produce and market generic sitagliptin [8]. Litigation surrounding patent challenges can affect the timeline for generic entry [4].